Filed: 5/15/2026ACC: 0000919574-26-003451
📋 What this filing means
CASDIN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 40 equity positions with a total reported market value of $1.32B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
40
Positions
$1.32B
Total AUM (reported)
142.45M
Total Shares
Allocation by class
COM$818.53M62.0%
COM CL A$207.65M15.7%
COM NEW$116.19M8.8%
SPONSORED ADS$76.62M5.8%
CL A COM$48.30M3.7%
CL A$15.75M1.2%
COM SHS$14.53M1.1%
Portfolio Concentration
Top 3$587.23M44.5%
4–10$433.04M32.8%
11–25$251.63M19.1%
Rest$48.69M3.7%
Top 3 weight
44.5%
Top 10 weight
77.3%
Voting Authority Distribution
Total shares with voting rights: 142.45M
Sole
Full voting authority
142.45M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole40
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings40
Rows:
REVOLUTION MEDICINES INC
SOLEShares2.58M
TypeSH
Market value$250.65M
18.98%
Sole
2.58M
Shared
0.00
None
0.00
GENEDX HOLDINGS CORP
SOLEShares3.01M
TypeSH
Market value$193.12M
14.62%
Sole
3.01M
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares14.42M
TypeSH
Market value$143.46M
10.86%
Sole
14.42M
Shared
0.00
None
0.00
BIOLIFE SOLUTIONS INC
SOLEShares5.96M
TypeSH
Market value$113.66M
8.61%
Sole
5.96M
Shared
0.00
None
0.00
STANDARD BIOTOOLS INC
SOLEShares88.78M
TypeSH
Market value$81.62M
6.18%
Sole
88.78M
Shared
0.00
None
0.00
ILLUMINA INC
SOLEShares530K
TypeSH
Market value$65.33M
4.95%
Sole
530K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares1.18M
TypeSH
Market value$56.63M
4.29%
Sole
1.18M
Shared
0.00
None
0.00
10X GENOMICS INC
SOLEShares2.27M
TypeSH
Market value$48.30M
3.66%
Sole
2.27M
Shared
0.00
None
0.00
DENALI THERAPEUTICS INC
SOLEShares1.84M
TypeSH
Market value$35.33M
2.68%
Sole
1.84M
Shared
0.00
None
0.00
BEAM THERAPEUTICS INC
SOLEShares1.35M
TypeSH
Market value$32.17M
2.44%
Sole
1.35M
Shared
0.00
None
0.00
GUARDANT HEALTH INC
SOLEShares315K
TypeSH
Market value$29.10M
2.20%
Sole
315K
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares1.42M
TypeSH
Market value$28.63M
2.17%
Sole
1.42M
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares75K
TypeSH
Market value$24.82M
1.88%
Sole
75K
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares758.86K
TypeSH
Market value$22.65M
1.72%
Sole
758.86K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares350K
TypeSH
Market value$17.21M
1.30%
Sole
350K
Shared
0.00
None
0.00
AGOMAB THERAPEUTICS NV
SOLEShares1.55M
TypeSH
Market value$16.26M
1.23%
Sole
1.55M
Shared
0.00
None
0.00
HIMS & HERS HEALTH INC
SOLEShares700K
TypeSH
Market value$14.53M
1.10%
Sole
700K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares3.25M
TypeSH
Market value$14.53M
1.10%
Sole
3.25M
Shared
0.00
None
0.00
QIAGEN NV
SOLEShares360K
TypeSH
Market value$14.41M
1.09%
Sole
360K
Shared
0.00
None
0.00
TEMPUS AI INC
SOLEShares294.13K
TypeSH
Market value$13.30M
1.01%
Sole
294.13K
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares553.27K
TypeSH
Market value$13.30M
1.01%
Sole
553.27K
Shared
0.00
None
0.00
GRAIL INC
SOLEShares230K
TypeSH
Market value$11.89M
0.90%
Sole
230K
Shared
0.00
None
0.00
PRIME MEDICINE INC
SOLEShares3.17M
TypeSH
Market value$11.02M
0.83%
Sole
3.17M
Shared
0.00
None
0.00
PERSONALIS INC
SOLEShares1.60M
TypeSH
Market value$10.19M
0.77%
Sole
1.60M
Shared
0.00
None
0.00
QUEST DIAGNOSTICS INC
SOLEShares50K
TypeSH
Market value$9.80M
0.74%
Sole
50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES INCSOLE | COM | 2.58M | SH | $250.65M 18.98% | 2.58M | 0.00 | 0.00 |
GENEDX HOLDINGS CORPSOLE | COM CL A | 3.01M | SH | $193.12M 14.62% | 3.01M | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 14.42M | SH | $143.46M 10.86% | 14.42M | 0.00 | 0.00 |
BIOLIFE SOLUTIONS INCSOLE | COM NEW | 5.96M | SH | $113.66M 8.61% | 5.96M | 0.00 | 0.00 |
STANDARD BIOTOOLS INCSOLE | COM | 88.78M | SH | $81.62M 6.18% | 88.78M | 0.00 | 0.00 |
ILLUMINA INCSOLE | COM | 530K | SH | $65.33M 4.95% | 530K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 1.18M | SH | $56.63M 4.29% | 1.18M | 0.00 | 0.00 |
10X GENOMICS INCSOLE | CL A COM | 2.27M | SH | $48.30M 3.66% | 2.27M | 0.00 | 0.00 |
DENALI THERAPEUTICS INCSOLE | COM | 1.84M | SH | $35.33M 2.68% | 1.84M | 0.00 | 0.00 |
BEAM THERAPEUTICS INCSOLE | COM | 1.35M | SH | $32.17M 2.44% | 1.35M | 0.00 | 0.00 |
GUARDANT HEALTH INCSOLE | COM | 315K | SH | $29.10M 2.20% | 315K | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 1.42M | SH | $28.63M 2.17% | 1.42M | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 75K | SH | $24.82M 1.88% | 75K | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 758.86K | SH | $22.65M 1.72% | 758.86K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 350K | SH | $17.21M 1.30% | 350K | 0.00 | 0.00 |
AGOMAB THERAPEUTICS NVSOLE | SPONSORED ADS | 1.55M | SH | $16.26M 1.23% | 1.55M | 0.00 | 0.00 |
HIMS & HERS HEALTH INCSOLE | COM CL A | 700K | SH | $14.53M 1.10% | 700K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 3.25M | SH | $14.53M 1.10% | 3.25M | 0.00 | 0.00 |
QIAGEN NVSOLE | ORD SHARES | 360K | SH | $14.41M 1.09% | 360K | 0.00 | 0.00 |
TEMPUS AI INCSOLE | CL A | 294.13K | SH | $13.30M 1.01% | 294.13K | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 553.27K | SH | $13.30M 1.01% | 553.27K | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 230K | SH | $11.89M 0.90% | 230K | 0.00 | 0.00 |
PRIME MEDICINE INCSOLE | COM | 3.17M | SH | $11.02M 0.83% | 3.17M | 0.00 | 0.00 |
PERSONALIS INCSOLE | COM | 1.60M | SH | $10.19M 0.77% | 1.60M | 0.00 | 0.00 |
QUEST DIAGNOSTICS INCSOLE | COM | 50K | SH | $9.80M 0.74% | 50K | 0.00 | 0.00 |
Page 1 of 2